Medicare and Medicaid
SNM Applauds Bill Allowing for Medicare Reimbursement of Essential Radiopharmaceuticals
Published in Hematology Week, July 28th, 2008
SNM, an international scientific and professional organization of more than 16,000 members, applauds Congress for overriding the presidential veto of the Medicare Improvements for Patients and Providers Act of 2008. This bill not only reverses a 10.6 percent cut in Medicare fees to physicians but also includes an 18-month extension of the 2007 reimbursement rates for vital radioimmunotherapies used in the treatment of cancer, neurological disease and many other types of debilitating and life-threatening illness.
"Thousands of patients will benefit and live longer if the government and private payers adequately reimburse highly effective radioimmunotherapies," said...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2008-07-28)
More Articles from Hematology Week
- Children's Hospital Boston
Gaining ground on sickle cell disease - Temple University
Tumor-inhibiting protein could be effective in treating leukemia - Universidad de Granada
Stem cells from umbilical cord used in the treatment of hepatic diseases - Blood Safety
Data on blood safety reported by researchers at University of Frankfurt - Bone Marrow
Study data from C. Dufour et al provide new insights into bone marrow - Cancer
New research on cancer from University of Texas summarized - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
